Palmer Square BDC's Q2 Yields Fell, but the $14.11 Price Still Says "Buy"

A softer quarter changed the setup, not the core debate

PSBD still looks like a buy, but mainly as a yield vehicle with a path to better earnings rather than a cheap stock today. After a softer Q2, the real bull-bear question is straightforward: can management keep the payout stable long enough for the next leg of earnings power to show up?

Bulls are focused on payout stability, not a perfect quarter. Q2 $0.39 per share NII was close to the current dividend bar, and management set a $0.36 per share Q3 base dividend while signaling a supplemental dividend could come later this year. That is the practical appeal here: investors do not need a flawless quarter, but they do need evidence the payout stream remains underpinned. Bears are right to note the pressure points. NII fell from $0.43 per share a year ago, and the $13.21 NAV is lower than the prior quarter. New buyers are still paying a $14.11 stock price, which works out to roughly a 7% premium over NAV.

Why timing matters more than the headline decline

The setup only works if the earnings recovery starts to show through. Management has said the funding reset should be accretive starting in Q4 2026. If that happens alongside continued dividend confidence, investors can hold for both income and possible earnings relief. If those signals weaken, paying a premium over NAV becomes much harder to defend.

What changed in Q2: lower scale, but no obvious break in coverage

The premium debate only matters if the payout engine is still intact. After Q2, that engine is smaller, but it does not look broken.

The mechanism: smaller asset base, similar coverage

The main change is scale, not collapse. Investment income fell 13.8% to $27.3 million, and NII dropped to $12.0 million from $13.8 million a year ago. On the surface, that looks weaker next to the dividend. But the key metric is coverage on the current base, not the year-over-year drop in income. Management declared a $0.36 base dividend for Q3, while Q2 NII was $0.39 per share. In other words, the current payout is broadly in line with what the current portfolio is producing. The immediate risk does not look like distribution failure; it looks more like whether earnings stay high enough while the asset base shrinks.

That shrinkage is real. Portfolio fair value fell to about $1.11 billion from $1.15 billion last quarter, NAV ticked down to $13.21 from $13.30, and Q2 deployment was $72.4 million across 21 new commitments versus about $109.8 million in repayments and sales. Fewer outstanding loans mean less coupon income, even if the remaining credits are still performing.

Credit problems still look contained

This is where the bull and bear cases diverge. Bears can argue the portfolio is rolling over too slowly and the earnings cushion is thinner. But credit quality still looks manageable. Nonaccruals were 0.29% on a fair value basis, and total net realized and unrealized losses improved to $3.6 million from $6.7 million a year ago. PIK income was about 1.37% of total investment income. Taken together, that suggests borrowers are mostly still paying in cash and the portfolio is not quietly building up distress.

The real question is no longer just whether credit problems are rising. It is whether management can redeploy capital fast enough to keep the payout covered.

What to watch next

For now, the signal still looks contained. This appears to be more of a runoff-and-reinvestment issue than a true credit-distress event.

The trade now comes down to coverage, valuation, and catalysts

This is less a story stock than a checklist.

The three numbers that matter most

First, $0.39 per share Q2 NII versus the $0.36 Q3 base dividend. That remains the clearest readthrough for payout coverage. It does not guarantee a comfortable setup for the next four quarters, but it does suggest management is not starting the next stretch from an obvious shortfall.

Second, the market is still asking investors to pay a $14.11 stock price against $13.21 NAV per share, roughly a 7% premium. In BDC terms, that is not extreme, but it does show the stock is not being traded like a distressed asset. If the premium holds while earnings improve, upside can come from both a firmer multiple and a stronger NAV base.

Third, leverage remains steady at 1.71x debt-to-equity. That matters because the bull case depends on the recent liability reset becoming a real earnings lever, not just a quote from management.

When the setup gets stronger

This is a payout-and-wait trade, not a pure deep-value trade.

• A supplemental dividend update confirms management still sees extra cash to return.
• Q4 results begin to show cost relief from the funding reset, as management has said the extension should be accretive starting in Q4 2026.
• The stock keeps trading at or above NAV as earnings visibility improves.

When the thesis weakens

• Supplemental dividend signals fade without offsetting earnings improvement.
• Debt-to-equity continues moving higher instead of stabilizing.
• The stock slips back toward or below NAV without better earnings visibility.

If PSBD becomes a NAV trade again, the case for buying it at $14.11 weakens materially.